Toll Free: 1-888-928-9744

Drugs For Benign Prostatic hypertrophy Global Market Report 2020

Published: Dec, 2019 | Pages: 200 | Publisher: The Business Research Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Drugs For Benign Prostatic hypertrophy Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global drugs for benign prostatic hypertrophy market.

Reasons to Purchase
• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies. 
• Create regional and country strategies on the basis of local data and analysis. 
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market. 
• Understand customers based on the latest market research findings. 
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description: 
Where is the largest and fastest growing market for the drugs for benign prostatic hypertrophy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Drugs For Benign Prostatic hypertrophy Market Global Report from The Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.
• The Market Characteristics section of the report defines and explains the market.
• The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
• Market Segmentations break down market into sub markets.
• The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing. 
• Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered:  1) By Type: Alpha Blocker,  5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, Others 2) By End User: Hospital Pharmacies, Retail Pharmacies, Others

Companies Mentioned: Allergan PLC,  Astellas Pharma Inc.,  Boehringer Ingelheim,  Eli Lilly and Company,  GlaxoSmithKline PLC

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
 Table of Contents

1. Executive Summary 2. Drugs for Benign Prostatic Hypertrophy Market Characteristics 3. Drugs for Benign Prostatic Hypertrophy Market Size And Growth 3.1. Global Drugs for Benign Prostatic Hypertrophy Historic Market, 2015 - 2019, $ Billion 3.1.1. Drivers Of The Market 3.1.2. Restraints On The Market 3.2. Global Drugs for Benign Prostatic Hypertrophy Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion 3.2.1. Drivers Of The Market 3.2.2. Restraints On the Market 4. Drugs for Benign Prostatic Hypertrophy Market Segmentation 4.1. Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Alpha Blocker 5-alpha Reductase Inhibitor Phosphodiesterase-5 Inhibitor Others 4.2. Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Hospital Pharmacies Retail Pharmacies Online Pharmacies 5. Drugs for Benign Prostatic Hypertrophy Market Regional And Country Analysis 5.1. Global Drugs for Benign Prostatic Hypertrophy Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 5.2. Global Drugs for Benign Prostatic Hypertrophy Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 6. Asia-Pacific Drugs for Benign Prostatic Hypertrophy Market 6.1. Asia-Pacific Drugs for Benign Prostatic Hypertrophy Market Overview 6.2. Asia-Pacific Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 6.3. Asia-Pacific Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 7. China Drugs for Benign Prostatic Hypertrophy Market 7.1. China Drugs for Benign Prostatic Hypertrophy Market Overview 7.2. China Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion 7.3. China Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion 8. India Drugs for Benign Prostatic Hypertrophy Market 8.1. India Drugs for Benign Prostatic Hypertrophy Market Overview 8.2. India Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 8.3. India Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 9. Japan Drugs for Benign Prostatic Hypertrophy Market 9.1. Japan Drugs for Benign Prostatic Hypertrophy Market Overview 9.2. Japan Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 9.3. Japan Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 10. Australia Drugs for Benign Prostatic Hypertrophy Market 10.1. Australia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 10.2. Australia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 11. Indonesia Drugs for Benign Prostatic Hypertrophy Market 11.1. Indonesia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 11.2. Indonesia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 12. South Korea Drugs for Benign Prostatic Hypertrophy Market 12.1. South Korea Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 12.2. South Korea Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 13. Western Europe Drugs for Benign Prostatic Hypertrophy Market 13.1. Western Europe Drugs for Benign Prostatic Hypertrophy Market Overview 13.2. Western Europe Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 13.3. Western Europe Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 14. UK Drugs for Benign Prostatic Hypertrophy Market 14.1. UK Drugs for Benign Prostatic Hypertrophy Market Overview 14.2. UK Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 14.3. UK Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 15. Germany Drugs for Benign Prostatic Hypertrophy Market 15.1. Germany Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 15.2. Germany Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 16. France Drugs for Benign Prostatic Hypertrophy Market 16.4. France Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 16.5. France Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 17. Eastern Europe Drugs for Benign Prostatic Hypertrophy Market 17.1. Eastern Europe Drugs for Benign Prostatic Hypertrophy Market Overview 17.2. Eastern Europe Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 17.3. Eastern Europe Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 18. Russia Drugs for Benign Prostatic Hypertrophy Market 18.1. Russia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 18.2. Russia Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 19. North America Drugs for Benign Prostatic Hypertrophy Market 19.1. North America Drugs for Benign Prostatic Hypertrophy Market Overview 19.2. North America Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 19.3. North America Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 20. USA Drugs for Benign Prostatic Hypertrophy Market 20.1. USA Drugs for Benign Prostatic Hypertrophy Market Overview 20.2. USA Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 20.3. USA Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 21. South America Drugs for Benign Prostatic Hypertrophy Market 21.1. South America Drugs for Benign Prostatic Hypertrophy Market Overview 21.2. South America Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 21.3. South America Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 22. Brazil Drugs for Benign Prostatic Hypertrophy Market 22.1. Brazil Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 22.2. Brazil Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 23. Middle East Drugs for Benign Prostatic Hypertrophy Market 23.1. Middle East Drugs for Benign Prostatic Hypertrophy Market Overview 23.2. Middle East Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 23.3. Middle East Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 24. Africa Drugs for Benign Prostatic Hypertrophy Market 24.1. Africa Drugs for Benign Prostatic Hypertrophy Market Overview 24.2. Africa Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 24.3. Africa Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion 25. Drugs for Benign Prostatic Hypertrophy Market Competitive Landscape And Company Profiles 25.1. Drugs for Benign Prostatic Hypertrophy Market Competitive Landscape 25.2. Drugs for Benign Prostatic Hypertrophy Market Company Profiles 25.2.1. Allergan PLC 25.2.1.1. Overview 25.2.1.2. Products and Services 25.2.1.3. Strategy 25.2.1.4. Financial Performance 25.2.2. Astellas Pharma Inc. 25.2.2.1. Overview 25.2.2.2. Products and Services 25.2.2.3. Strategy 25.2.2.4. Financial Performance 25.2.3. Boehringer Ingelheim 25.2.3.1. Overview 25.2.3.2. Products and Services 25.2.3.3. Strategy 25.2.3.4. Financial Performance 25.2.4. Eli Lilly and Company 25.2.4.1. Overview 25.2.4.2. Products and Services 25.2.4.3. Strategy 25.2.4.4. Financial Performance 25.2.5. GlaxoSmithKline PLC 25.2.5.1. Overview 25.2.5.2. Products and Services 25.2.5.3. Strategy 25.2.5.4. Financial Performance 26. Key Mergers And Acquisitions In The Drugs for Benign Prostatic Hypertrophy Market 27. Drugs for Benign Prostatic Hypertrophy Market Trends And Strategies 28. Product Pipeline Analysis 29. Drugs for Benign Prostatic Hypertrophy Market Future Outlook and Potential Analysis 30. Appendix 30.1. Abbreviations 30.2. Currencies 30.3. Research Inquiries 30.4. The Business Research Company 30.5. Copyright And Disclaimer
List of Tables

Table 1: Global Historic Market Growth, 2015-2019, $ Billion Table 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion Table 3: Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 4: Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 5: Global Drugs for Benign Prostatic Hypertrophy Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 6: Global Drugs for Benign Prostatic Hypertrophy Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 7: Asia-Pacific, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 8: Asia-Pacific, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 9: China, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 10: China, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 11: India, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 12: India, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 13: Japan, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 14: Japan, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 15: Australia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 16: Australia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 17: Indonesia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 18: Indonesia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 19: South Korea, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 20: South Korea, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 21: Western Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 22: Western Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 23: UK, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 24: UK, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 25: Germany, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 26: Germany, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 27: France, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 28: France, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 29: Eastern Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 30: Eastern Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 31: Russia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 32: Russia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 33: North America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 34: North America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 35: USA, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 36: USA, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 37: South America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 38: South America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 39: Brazil, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 40: Brazil, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 41: Middle East, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 42: Middle East, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 43: Africa, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 44: Africa, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Table 45: Allergan PLC Financial Performance Table 46: Astellas Pharma Inc. Financial Performance Table 47: Boehringer Ingelheim Financial Performance Table 48: Eli Lilly and Company Financial Performance Table 49: GlaxoSmithKline PLC Financial Performance


List of Figures

Figure 1: Global Historic Market Growth, 2015-2019, $ Billion Figure 2: Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion Figure 3: Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 4: Global Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 5: Global Drugs for Benign Prostatic Hypertrophy Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 6: Global Drugs for Benign Prostatic Hypertrophy Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 7: Asia-Pacific, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 8: Asia-Pacific, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 9: China, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 10: China, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 11: India, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 12: India, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 13: Japan, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 14: Japan, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 15: Australia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 16: Australia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 17: Indonesia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 18: Indonesia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 19: South Korea, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 20: South Korea, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 21: Western Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 22: Western Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 23: UK, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 24: UK, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 25: Germany, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 26: Germany, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 27: France, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 28: France, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 29: Eastern Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 30: Eastern Europe, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 31: Russia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 32: Russia, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 33: North America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 34: North America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 35: USA, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 36: USA, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 37: South America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 38: South America, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 39: Brazil, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 40: Brazil, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 41: Middle East, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 42: Middle East, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 43: Africa, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 44: Africa, Drugs for Benign Prostatic Hypertrophy Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion Figure 45: Allergan PLC Financial Performance Figure 46: Astellas Pharma Inc. Financial Performance Figure 47: Boehringer Ingelheim Financial Performance Figure 48: Eli Lilly and Company Financial Performance Figure 49: GlaxoSmithKline PLC Financial Performance

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $4000
Multi User - US $8000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify